Silo Pharma SILO
NASDAQ SILO
$1.50 -0.01 (-0.86%)
As of: Oct 1, 2026 · 3:59 PM EDT

Silo Pharma (SILO) Accumulated Expenses (2022 - 2023)

Updated

Silo Pharma (SILO) recorded Accumulated Expenses of $5,891 in Q4 2023, down 70.7% from $20,134 a year earlier.

Analysis

Silo Pharma (SILO) Accumulated Expenses (2022 - 2023) Analysis & Trends

  • Across earlier years, Accumulated Expenses came in at $20,134 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Silo Pharma 1.70 Mn 1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5,891.00
Mar 31, 2023 20,134.00
Dec 31, 2022 20,134.00
API Access

Silo Pharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SILO&period=max&api_key=YOUR_API_KEY